Member Info for G_G_G

SS, I'm more worried that you're dementing. If anyone from Nigeria calls offering you the deal of a lifetime, just say No. You can thank me later.

I want to understand the connection between JJR Wood and our bod. They bent us over for $12.5m @ 16p not including fees. Not exactly pocket change that got called on.

you need to sort your story out ss. have i bought back in after trashing the sp (not pb doing it), or was i never in and locked into tig...? you need to choose whatever story makes you feel better and stick to it. and if you knew me from i3e or shg then you'd understand that 1.35m shares is less than 30% of my busted up pf. i should have invested less and had more money, but thanks to lyin paul he's f@cked that horizon this year.

tell me what i've missed, zero? all i can see is free shares for f@cking things up, freeloader director buy in the 13's, placement at 16p after f@cking up the other placement that was over 25% higher (and to whom we don't know), d@g**** q2 results, and reference to an investor presentation promising jam tomorrow. did i miss anything from calamity baay and his merry band of free-loaders?

Whouse, that would ordinarily be the case for a CEO and a company that has a strong track record of delivery. But we're talking about Calamity Baay, a charlatan CEO who likes to mislead and withhold information from investors.

Only in the past year we've had him drag out the acquisition to the last minute. Everyone was told 'don't worry it's just paperwork' and instead we went to the wire, and then went to a bucket shop for a last-minute raise that we were told wouldn;t be necessary. We also didn't know about the issues with Casc 4 for months. Everyone thought it was done and dusted, and the next news would be flow rates, only to discover they had drilled for months only getting halfway and blowing the budget to pieces in the process. Then there's the raise money not being forthcoming. We were told ONE MONTH past settlement date that the funds hadn't been received. Everyone thought it had been sorted, and we were drilling Casc 5.

So in no way is 'no news is good news' with this company. Calamity Baay is one of those slippery types who decides to wait until he's forced to say something, by which time he has something shiny in his other hand to promise the market and all the lemmings refocus on the next thing, rather than the long list of f@ck ups.

The sp says no one trusts the guy. And until the useless clown releases an ops statement on Casc 4, and Central now being drilled, investors will now fear the worst. I'm neck deep with 1.35m shares. That lying joke of a CEO has cost me over £80k at today's share price, plus 6 months of no movement, and if he had even a modicum of competence to close a straightforward acquisition plus raise, we would now be double the current sp. Getting to the high 20's seems like a dream given we are STILL WAITING CASC 4 NEWS. Drilling was meant to start Q4 2024. Until we hear it's been completed and getting hooked up and Central now being drilled, the market will not take a second look here and will instead fear the worst.

Btw, has our connection to Calamity Baay, John, heard anything? I'd surmise if Lyin Paul is ducking his emails that we have yet another problem on our hands. If so, will PIs finally band together to have him removed...? Perhaps John can also ask who the new major investor is at 16p - I'd love to know if there's any connection to Baay or the government. Arguably the most incompetent and least trustworthy CEO on AIM. To have the assets and funding he has been given, and this is where things stand, is all the evidence you need to back up that statement.

'Good news tomorrow' sounds like something straight out of the @ss of the ramper in front of you, SS.

But on a serious note, has anyone near the front of the human centipede been given anything useful from Calamity Baay, or has the dog eaten his homework again, and he's trying to think of another story to tell us? For someone who gets nearly $800k per year to make investors poorer, you'd think the useless pr!ck could at least keep us informed of where things stand on his latest promises.

Agree Stas. I'm genuinely amazed the HE1 crew and the general herd haven't arrived. The numbers for JS1 are extraordinary. Even if JS2 is half the level, you are still looking at wells delivering anywhere between $7-15m per year depending on constrained flow rates. If they can sort out JS2, we'll also have two producers ready to hook up. Those numbers also relate to He priced at $550, which is almost half what NASA pays. I think it's going to be one of those shares where it plods along, and then we get one or two delineation wells plus a resource statement, and the sp takes off and doubles within a week. Hopefully something good happens over at TXP in the coming months, and I can add more to my pile here. I'm down 15% at the moment on 400k shares. Very confident that we'll be 50-100% higher in 6 months. AIMHO GLA

SM, what's your holding and average now?

They were my 100k and 50k buys between 13.8 and 13.94p. Average now 19.9p for 1.35m.

Full disclosure, I dumped my 825k holding this morning just after 8am. Been smashed with work so only posting now. I still believe this will be 3x the current share price in a couple of years. But that's a couple of years away, and for the near future, I think it's going to be pegged closer to 8p as traders exit. I'm trying to think more like the herd, rather than as an investor. Good 20% gains for me. Just a shame I missed out on the extra 10-20%. Had they added $10m & $20m to years 2 & 3 forecast numbers then I think this would be closer to 15p. Not sure if they have sandbagged the results, but think any more gains up to double digits is going to depend on some more good news. This is just one more collaboration away from regaining double digits quickly. I'll be back. GLA

How do you get to a resource estimation if you're not testing the He concentrations? And yes, I'd expect flow testing to be done as well, otherwise how do you delineate the size of the footrpint?

Hit 9.5p and bounced 5%. I won't be surprised if it happens again. I'd be quite happy if this drops to 9p as I can grab some more. Raise is f'all and I highly doubt the new money will be selling for 10-20% gains. Same goes for PIs, the majority of whom are under water. Another good collaboration/partnership announcement, or confirmation of cash flow +ve within 6 months and this will hit 20p in days. We have also had a t/o approach last year so won't be surprised if another happens int he coming months. I imagine any offer would need to at least cover the costs invested to get us here, which is roughly 3x the current mcap plus additional raise funds. Hopefully a bit more selling to drop us to 9p or lower. Sorry fellas but I want to keep my average near 8p if I'm adding a lot more shares. Very exciting future prospects for this company.

Let's hope so Marty, because if the forecasts are upgraded significantly, we will be at 15p in a flash. I've got cash at the ready for the raise or below 9.5p. The potential here is so unbelievably massive in terms of patient care, market size, national healthcare support, and being the only test of its kind approved by the FDA. Quite mindblowing really. Best of all, they are cashed up for an accelerated scale up. If the sp stays above 9.5p we should see an oversubscribed placing. That will be a very good sign for future sp appreciation. And some more significant +ve news in the coming weeks could send this on a HEMO / IMM trajectory.

Kat, I'm not sure if there are that many shares in the 6-7p range given the low volume in this channel. Many new shareholders would have bought much higher in the spike to 15p and the levels above 8p as it dropped back down with POLAR selling. There's been about 150m of volume since the Tempus announcement. Reckon the average for those shares would sit around 8.5p. Any lth's averaging down, of which there would be many, would still have a b/e above 10p given where the sp has been the past few years.

Either way, there will be traders, but not many with large holdings and averages below 8p. And anyone with an understanding of the potential here, with a raise designed to rapidly scale the product, would no doubt be wanting to see 15p or more for their money. As I said, I'll buy heavily if we drop below the placing price in the next week. And by that I mean at least another 1m shares. Most others will do the same, which is why it's unlikely to stay in single digits for very long. AIMHO GLA

Louise, stupid comments about the recent lows of the share price and extrapolation. If you are even remotely informed on the company, you would know there has been a major institutional shareholder selling off, causing the drop to 6-7p. Once they had completely sold out you saw a jump to 12p. This is the real impact of the Tempus AI announcement before the current raise, or do you want to argue that a $15bn company collaboration massively extending product reach won't be transformative for RENX? That's a collab with a company that would be a mid-table FTSE 100 constituent. And no doubt there's more to come. Not to mention non-US roll-out.

Placing at 9.5p for circa $6m is unfortunate, but not unexpected. Funnily enough, the values are pretty close to what I said they would do if funds are required just a few days ago. Ultimately, it's a good price. It is for a relatively small amount, which I assume they have restricted because they know in 6 months the sp will be considerably higher. And the Directors have committed a pretty decent chunk of cash. I'm unsure how much was needed, versus how much will go to Tempus, but even with a continued cash burn of $800k per month they should have enough total cash to cover at least 9 months of scale up. Tempus AI collab, combined with on-going efforts and another collaboration (or two), and the cash burn may be non-existent in 3-4 months.

As for this week, I expect the share price to stick around the placing price for a few weeks whilst traders from the 7p range decide to chase other rainbows. It's not a lot of shares to get through that would be churned below 10p, as most would be under-water, even at 9.5p. If the sp is near or drops below the placing price in the coming days, then I don't expect it to be oversubscribed. PIs complain a lot about not being offered an opportunity to participate, but then rarely take the full offer when it is presented.

I'd be very surprised if we dip below 9p, and if so it will be snapped up quickly, me included. Once minor churn is done, then I think we will need another announcement as a catalyst to drive past 15p. Not much required and could be as simple as the CEO stating no more fundraises, upgrading 12 & 24 month forecasts, and cashflow +ve in less than 6 months. That's all the market needs to hear for this to churn traders and re-rate again on the back of massive PI interest. I imagine money from IMM and HEMO will start to flow into here, given the significantly better prospects here to double your money in 3 months versus either of those stocks. AIMHO GLA

This should be at least 20p given its lifestage, recent Tempus news, and potential annual market value with single digit penetration in the US alone. For me, it has far more value accretion opportunity than HEMO and IMM in the coming years. Unless I'be got this wrong, they have years and hundreds of millions of $ before they have treatments that can be rolled out to patients. Clincial trials, FDA approval etc, takes a huge amount of resources. And then you need adoption and scaling of your novel approach / treatment. We already have development and FDA approval in the bag after many years and over $100m invested. We have also started scaling availability and adoption, which has just taken a huge step forward with Tempus. There will be more partnerships, and more geographies to come. This is the start of the hockey stick, and if I was given a choice between the 3 companies there's no doubt this is the one that is most advanced toward commercialisation. Market size is immense in the US alone. And what it can do to patient lives is extraordinary. If we drop back to single digits, I'll add to my holdings. Excited for tomorrow. GLA

BB3, the major newsflow here over from end-October for the following 6 months is going to be fortnightly. So many things to release that can add 10-20%. I think what's going to happen is we'll stay under the radar until the next couple of wells are drilled and Thomas starts talking about it being +1bcf and He% consistently hitting +5%. That's when folks will realise this should be priced at 2-3x the current value. We now know this is highly commercial on two wells. We've already got a loan lined up, and a mgt team with a huge amount of skin in the game and an aversion to dilution. Just need to see a high confidence in a resource upgrade and we're laughing. I think there's a very good chance that we have a +$1bn resource that's going to be sucked dry in the next 15 years for less than an additional $100m. If He goes to $1000 in that time then you have a multi-billion $ resource. I'm going to be adding so happy for this to stay down here for a few more weeks. The news I needed on flow rates and He % are now known. GLA

Hi Guys, sorry crazy work plus family visiting, so not posting yesterday when we got the blindingly good news. At some point, the herd is going to wake up to this, and it will double in the space of a week. The news is mindbogglingly good. Folks need to keep in mind the low costs of producer wells, and the low cost of the infrastructure at $10-50m, depending on the size of the plant. Here are some simple numbers on what they have just announced.

He% 7.5% (mid-point). He value $550. Co2% 77.5% (mid-poont). CO2 value $25. Both conservative revenue values. 330 days production.

JS1 sustained flow rate at 0.75mcf Annual Revenue - $10.2m (He) + $4.8m (CO2) = $15m per well, per annum.

JS1 sustained flow rate at 0.50mcf Annual Revenue - $6.8m (He) + $3.2m (CO2) = $10m per well.

Obviously there will be decline rates, but these are astounding numbers. Production wells will cost $1-2m. The market is absolutely sleeping on this. If they prove up 1bcf recoverable He Resource, which again is relatively conservative, the numbers are:

He + CO2 Resource Value - $550m + $250m. = $800m. This is working off conservative pricing of $550mcf (He) + 25mcf (CO2).

The lifetime value of such a resource is likely to be well in excess of $1bn given NASA pays more than $1000mcf for their long term supply contracts.

I've been very fortunate to have thrown over £60k into RENX on Wednesday and Thursday, which I think has further to run. I'll most certainly be pulling money from there at some point if it continues its rapid climb and throw it in here. TXP will also get some money pulled and put in here if the f@ckwit mgt team can drill a hole and get us back to the last placing price.

Looks like a very easy bag in the next 6 months, with potential to 2-3x with a bigger than expected resource footprint. Just silly numbers if you think of 10x wells, even at 0.3mcf and the same He concentrations. For $50m ($35m Plant + $15m wells), you will be throwing off $60m in Revenue with declines being offset by $1.5m wells. Crazy, crazy numbers that can realistically be achieved in less than 2 years. When up and running this will be a $250m / £190m Mcap (x 4 Revenue multiple). Even with well-timed dilution of $25m, the sp will be comfortably sitting at £1 in less than 24 months on the current estimated resource size.

Happy for folks to try and pull those numbers apart. I think 0.3mcf per well, and the resource values used, makes these numbers quite conservative. Happy to be proven wrong. GLA

Been out all day but keeping an eye on recent re-rate. I picked up 820k of these yesterday and the day prior for 6.7p average :) I'd love it to keep going to 20p. Then I might start selling down my holdings. If it gets the Hemo treatment it could triple from the current sp in the next couple of weeks. I also don't understand how Hemo is worth so much more - Far better prospects here. GLA

yes mikey. my response was to point out why any placing (if required) would be for a relatively small amount given they are well into revenue scale-up stage and it would be in the double digits given the recent tie-up with a multi-billion dollar company. point being, if we need cash it will be small. and the raise price will be at a healthy premium to where things currently stand. it wouldn't bother me at all if they raised $5m for the very last time at 12p. at least you'd know it's not going to happen again, and they can get on wiht scaling the **** out of this business in the us and uk.

f@cking nuts this isn't a core part of the nhs offering. a british health-tech company that can save the country billions and it's not being heralded by the uk government.

Pharmhall, you are right in pointing out the risk of a placing. And yes, there is a chance of it occurring. Having said that, they last raised cash 10 months ago when the sp was 8p. They raised over £11m at 9p, which was a 12.5% premium to the sp. So what's the worst that can happen now when the business is rapidly scaling and the sp is 8.5p? Given recent news and the current growth trajectory, I think they could find a cornerstone investor to front a maximum of USD$4-5m for a double-digit share value very easily. That's all they would need to get the company to FY27 where the revenue starts to roll-in. It's pocket change for Mount Sinai, and they'd receive another 10-12.5% of the enlarged share count. Either way, I cannot see them raising for a relatively modest value in the single digits, given where things currently stand. Much greater likelihood of them accepting a t/o offer at +20p.

Another whopping volume day and taking the total past 100m in the past 4 sessions. It will start to cool off, but I believe there's a lot more good news to come in the next year. And another raise happening wouldn't be bad news if it means we don't ever have to worry about one again, and the raise value is less than $5m and price is double digits. That would be the worst case scenario imo. Will certainly be interesting to see what tomorrow brings. GLA